Effects of Isotlavones Supplemented Diet on Lipid Concentrations and Hepatic LDL Receptor mRNA Level in Growing Female Rats

성장기 암컷 흰쥐에서 이소플라본 첨가 식이가 지질 농도와 간 LDL 수용체의 유전자 발현정도에 미치는 영향

  • Choi Mi-Ja (Department of Food and Nutrition, Keimyung University, Department of Health and Medicinal Food, World Cyber College) ;
  • Jo Hyun-Ju (Department of Food and Nutrition, Keimyung University, Department of Health and Medicinal Food, World Cyber College)
  • 최미자 (계명대학교 식품영양학과, 세계사이버대학 약용건강식품전공) ;
  • 조현주 (계명대학교 식품영양학과, 세계사이버대학 약용건강식품전공)
  • Published : 2005.06.01

Abstract

The purpose of this study was to examine the impact of isoflavones on lipid concentrations and hepatic LDL receptor mRNA level in growing female rats. Twenty four rats (body weight $75\pm5g$) were randomly assigned to one of two groups, consuming control diet or isoflavones supplemented diet (57mg isoflavones/100g diet). All rats has been fed on experimental diet and deionized water ad libitum for 9 weeks. The concentration of triglyceride and total cholesterol were measured in serum and liver. Serum HDL cholesterol was measured. Hepatic LDL receptor mRNA level was tested by RT-PCR. Supplementation of isoflavones did not affect weight gain, mean food intake and food efficiency ratio. Serum total cholesterol and non-HDL cholesterol of isoflavones supplemented rats were significantly lower than those of control rats (p<0.05). But hepatic cholseterol was not influenced by supplementation of isoflavones. Hepatic LDL receptor mRNA level not significantly different between control group and isoflavones supplemented group. Therefore, isoflavones may be beneficial on serum cholesterol and non-HDL cholesterol lowering in growing female rats.

References

  1. Kurowska EM, Carroll KK. Hypercholesterolemic responses in rabbits to selected groups of dietary essential amino acids. J Nutr 124: 364-370,1994
  2. Kritchevsky D. Dietary protein and experimental atherosclerosis. Ann NYAcad Sci 676: 180-187, 1993 https://doi.org/10.1111/j.1749-6632.1993.tb38733.x
  3. Huff MW, Carroll KK. Effects of dietary proteins and amino acid mixtures on plasma cholesterol levels in rabbits. J Nutr 110: 1676-1685,1980
  4. Shorey RL, Day PJ, Willis RA. Effects of soybean polysaccharide on plasma lipids. J Am Diet Assoc 85: 1461-1465, 1985
  5. Klevay LM. Coronary heart disease: the zinc/copper hypothesis. Am J Clin Nutr 28: 764-774,1975
  6. Sidhy GS, Oakenfull DG. A mechanism for the hypocholesterolemic activity of saponins. Br J Nutr 55: 643-649, 1986 https://doi.org/10.1079/BJN19860070
  7. Anthony MS, Clarkson TB, Hughes, CL, Morgan TM, Burke GL. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutr 126: 43-50, 1996
  8. Messina M, Messina V. Soyfoods, soybean isoflavones, and health: A brief overview. J Ren Nutr 10: 63-68, 2000 https://doi.org/10.1016/S1051-2276(00)90001-3
  9. Jayo MI, Anthony MS, Register C, Rankin SE, Best T, Clarkson TB. Dietary soy isoflavones and bone loss; a study in ovariectomized monkeys. J Bone Mineral Res 11: s228 (abstr), 1996
  10. Miksick RI. Estrogenic flavonoids: Structural requirements for biological activity. Proc Soc Exp Bioi Med 208: 44-50, 1995
  11. Kuiper GJM, Lemmen JG, Calsson B. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor $\beta$. Endocrinology 139: 4252-4263, 1998 https://doi.org/10.1210/en.139.10.4252
  12. Tavia G, William BK. Menopause and coronary heart disease: Framingham study. Ann Intern Med 89: 157-161, 1978
  13. Jayagopal V, Albertazzi P, Kilpatrick ES, Howarth EM, Jennings PE, Hepburn DA, Atkin SL. Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care 25: 1709-1714,2002 https://doi.org/10.2337/diacare.25.10.1709
  14. Goodman GD, Kritz SD. Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women. J Nutr 131: 1202-1206, 2001
  15. Takatsuka N, Nagata C, Kurisu Y, Inaba S, Kawakami N, Shimizu H. Hypocholesterolemic effect of soy milk supplementation with usual diet in premenopausal normolipidemic Japanese women. Prev Med 31: 308-314, 2000 https://doi.org/10.1006/pmed.2000.0714
  16. Wong WW, Smith EO, Stuff IE, Hachey DL, Heird WC. Cholesterol lowering effect of soy protein in normocholesterolemic and hypercholesterolemic men. Am J Clin Nutr 68 (suppI): 1385s-1389s, 1998
  17. Makela S, Davis VL, Tally we. Dietary estrogens act through estrogen receptor mediated processes and show no anti-estrogenicity in cultured breast cancer cells. Environ Health Perspect 102: 572-578, 1994
  18. Martin RM, Horwitz KB, Ryan DS, McGuire WL. Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology 198: 1860-1867, 1978
  19. Dwyer IT, Goldin BR, Saul N, Gualtieri L, Barakat S, Adlercreutz H. Tofu and soy drinks contain phytoestrogens. J Am Diet Assoc 94: 739-743, 1994 https://doi.org/10.1016/0002-8223(94)91939-9
  20. Setchel KDR, Nechemias LZ, Cai J, Heubi IE. Isoflavones content of infant formulas and the metabolic rate of these phytoestrogens in early life. Am J Clin Nutr 68 (suppI) : 1453s-1461s, 1998
  21. Badger TM, Ronis MJ, Hakkak R, Rowlands JC, Korourian S. The health consequences of early soy consumption. J Nutr 132 (suppI) : 559s-565s, 2002
  22. Strong JP, Malcom GT, McMahan CA. Prevalence and extent of atherosclerosis in adolescents and young adults. JAMA 281: 727- 735, 1999 https://doi.org/10.1001/jama.281.8.727
  23. National institutes of health, national heart, lung, and blood institute. Report of the expert panel or blood cholesterol levels in children and adolescents. National Cholesterol Education Program. Bethesda. Nlli Publication No. 91-27-32, 1991
  24. Reeves PG, Nielsen PH, Fahey GC. AIN-93 purified diets for laboratory rodents. J Nutr 123: 1939-1951, 1993
  25. Choi MJ, Cho HJ. Effects of soy isoflavones on bone mineral density in growing female rats. Korean J Nutrition 36: 359-367, 2003
  26. Haglund O, Loustarinen R, Wallin R, Wibell I, Saldeen T. The effect of fish oil on triglycerides, cholesterol, fibrinogen and malondialdehyde in humans supplemented with vitamin. Eur J Nutr 121: 165-172,1991
  27. Folch J, Lees M, Sloanestanley GH. A simple method for the isolation and purification of total lipids from animal tissue. J BioI Chem 226: 497-509,1957
  28. Bustin SA. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR) : trends and problems. J Mol Endocrinol 29: 23-39, 2002 https://doi.org/10.1677/jme.0.0290023
  29. A1jmandi AH, Getlinger MJ, Goyal NV, Alekel L, Hasler CL, Juma S, Drum ML, Hollis BW, Kukreja Sc. Role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian honnone deficiency in rats. Am J Clin Nutr 68 (suppI) : 1358s-1363s, 1998
  30. Kim MS. Beneficial effect of soy isoflavone on bone loss and hyperlipidemia in ovariectomized rats. Ph D Dissertation. Seoul National University, Seoul, 1999
  31. Picherit C, Bennetau-Pelissero C, Chanternne B, Lebecque P, Cavicco MJ, Barlet JP, Coxam V. Soybean isoflavones dose-dependently reduce bone turnover but do not reverse established osteopenia in adult ovariectomized rats. J Nutr 131: 723-728, 2001
  32. Hsu CS, Shen WW, Hsueh YM, Yeh SL. Soy isoflavone supplementation in postmenopausal women. Effects on plasma lipids, antioxidant enzyme activities and bone density. J Reprod Med 46: 221-226, 2001
  33. Wangen KE, Duncan AM, Xu X, Kurzer MS. Soy isoflavones improve plasma lipids in nonnochoiesterrolemic and mildly hypercholesterolemic postmenopausal women. Am J Clin Nutr 73: 225-231,2001
  34. Schouw IT, Kliijn MJ, Peeters PH, Grobbee DE. Phytoestrogens and cardiovascular disease risk. Nutr Metab Cardiovasc Dis 10: 154-167,2000
  35. Lichtenstein AH. Soy protein, isoflavonoids, and risk of developing coronary heart disease. Curr Taheroscler Rep 1: 210 -214, 1999 https://doi.org/10.1007/s11883-999-0034-6
  36. Merz-Demlow BE, Duncam AM, Wangen KE, Carr TP, Xu X. Soy isoflavones improve plasma lipid in nonnochoiesterolemic premenopausal women. Am J Clin Nutr 71: 1462-1469, 2000
  37. Teixeira BH. Effects of feeding 4 levels of soy protein for 3 and 6 week on blood lipids. Am J Clin Nutr 71: 1074-1084,2000
  38. Balmir F, Staack R, Jeffrey E, Jimenz MOB, Wang L, Potter SM. An extract of soy flour influences serum cholesterol and thyroid honnones in rats and hamsters. J Nutr 126: 3046-3053, 1996
  39. Zhan S, Ho Sc. Meta-analysis of the effects of soy protein containing isoflavones on the lipid proftle. Am J Clin Nutr 81: 397-408,2005
  40. Anthony MS, Clarkson TB, Williams JK. Effects of soy isoflavones on atherosclerosis: Potential mechanisms. Am J Clin Nutr 68 (suppI) : 1930s-1933s, 1998
  41. Baum JA, Teng H, Erdman JW Jr. Long-tenn intake of soy protein improves blood lipid proftles and increases mononuclear cell low density lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women. Am J Clin Nutr 68: 545-551, 1998
  42. Brown MS, Goldstein JL. Receptor-mediated control of cholesterol metabolism. Science 191: 150-154, 1976 https://doi.org/10.1126/science.174194
  43. Li C, Briggs MR, Ahlborn TE, Kraemer FB, Liu J. Requirement of Sp 1 and estrogen receptor alpha interaction in 17 beta-estradiol mediated transcription activation of the low density lipoprotein receptor gene expression. Endocrinology 142: 1546-1553, 2001 https://doi.org/10.1210/en.142.4.1546
  44. Borradaile NM, de Dreu LE, Wilcox LJ, Edwards JY, Huff MW. Soya phytoestrogens, genistein and daidzein, decrease apolipoprotein B secretion from HepG2 cells through multiple mechanisms. Biochem J 366 (Pt 2) : 531-539, 2002 https://doi.org/10.1042/BJ20020046
  45. Carroll KK, Kurowska EM. Soy consumption and cholesterol reduction: Review of animal and human studies. J Nutr 125 (suppI) : 594s-597s, 1995
  46. Lovati MR, Manwni C, Canavesi A. Soybean protein diet increases low density lipoptotein receptor activity in mononuclear cells from hypercholesterolemic patients. J Clin Invest 80: 1498-1502, 1987 https://doi.org/10.1172/JCI113232
  47. Sirtori CR, Lovati MR, Manwni C. Soy and cholesterol reduction: Clinical experience. J Nutr 125 (suppI) : 598s-605s, 1995